CarMa Seed Fund backs the ideas others aren't ready for yet — with the conviction that the most consequential companies are funded before the consensus forms.
CarMa Seed Fund is our in-house investment vehicle — deploying capital into the founders and companies redefining what is possible across life sciences, artificial intelligence, and deep technology. Returns matter. But the real motivation is seeing what nobody else sees yet, and backing it before the world catches up.
"We invest with provocative conviction. Not in what is safe, but in what is consequential — in the ideas that uplift humanity and push forward the next generation of what is possible."
We back ideas before the category exists
The rigour of the science tells us when to move
We write our first cheque at pre-seed and stay through Series C
A CarMa cheque is more than capital. It is a signal — to Eastern markets, to APAC, to the sovereign relationships we have built over decades — that we believe. And when we believe, the network pays attention.
Every CarMa investment enters automatic consideration for CarMa Institute — the IR engine, narrative strategy, and capital market access turn on from day one
We sit alongside the founders we back — advising on globalization, MENA and APAC market entry, and the strategic decisions that determine whether a company becomes a category
We connect the founders we back with the most powerful relationships we know — sovereign offices, royal family offices, and institutional allocators across MENA and APAC
Most investments begin with a recommendation from within the CarMa network — a founder we already back, a partner we trust, or a relationship that brings someone to our attention.
Some begin in person — a company whose science stops us in a room. We attend a small number of events each year. When we find something real, we follow up.
One conversation. If the science is real, the founder is extraordinary, and the vision is consequential — we move. We don't wait for the world to agree first.
Investments are considered through referral and conference introduction only.